BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31338877)

  • 1. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
    Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
    J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
    Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
    Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and
    Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
    World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity.
    Hong GB; Zhou JX; Yuan RX
    Int J Nanomedicine; 2012; 7():2863-72. PubMed ID: 22745549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
    Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
    Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles.
    Guo Q; Liu Y; Xu K; Ren K; Sun W
    Int J Nanomedicine; 2013; 8():2273-84. PubMed ID: 23818783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell lines.
    He Y; Song W; Lei J; Li Z; Cao J; Huang S; Meng J; Xu H; Jin Z; Xue H
    Acta Radiol; 2012 Nov; 53(9):1049-58. PubMed ID: 23012484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer.
    Deng L; Ke X; He Z; Yang D; Gong H; Zhang Y; Jing X; Yao J; Chen J
    Int J Nanomedicine; 2012; 7():5053-65. PubMed ID: 23028227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
    Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody.
    Liu F; Le W; Mei T; Wang T; Chen L; Lei Y; Cui S; Chen B; Cui Z; Shao C
    Int J Nanomedicine; 2016; 11():2195-207. PubMed ID: 27274243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging.
    Chen X; Zhou H; Li X; Duan N; Hu S; Liu Y; Yue Y; Song L; Zhang Y; Li D; Wang Z
    EBioMedicine; 2018 Apr; 30():129-137. PubMed ID: 29574092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.
    Zhao M; Liu Z; Dong L; Zhou H; Yang S; Wu W; Lin J
    Int J Nanomedicine; 2018; 13():4433-4443. PubMed ID: 30122918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2-functionalized ultrasmall superparamagnetic iron oxide nanoparticles coated with amphiphilic polymer enhance the labeling efficiency of islets for detection by magnetic resonance imaging.
    Yang B; Cai H; Qin W; Zhang B; Zhai C; Jiang B; Wu Y
    Int J Nanomedicine; 2013; 8():3977-90. PubMed ID: 24204136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted SPION siderophore conjugate loaded with doxorubicin as a theranostic agent for imaging and treatment of colon carcinoma.
    Nosrati R; Abnous K; Alibolandi M; Mosafer J; Dehghani S; Taghdisi SM; Ramezani M
    Sci Rep; 2021 Jun; 11(1):13065. PubMed ID: 34158526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
    Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication of deferasirox-decorated aptamer-targeted superparamagnetic iron oxide nanoparticles (SPION) as a therapeutic and magnetic resonance imaging agent in cancer therapy.
    Moghadam SMM; Alibolandi M; Babaei M; Mosafer J; Saljooghi AS; Ramezani M
    J Biol Inorg Chem; 2021 Feb; 26(1):29-41. PubMed ID: 33156416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Characterization of PLGA-based Magnetic Polymer Nanoparticles for Targeting Pancreatic Adenocarcinoma.
    Lu L; Jie L; Zhou Y; Zhang J; Feng T; Zhu Y; Chen T; Zhu X; Ji J; Wang Z
    Curr Pharm Des; 2023; 29(9):686-696. PubMed ID: 36967466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo.
    Shanehsazzadeh S; Gruettner C; Lahooti A; Mahmoudi M; Allen BJ; Ghavami M; Daha FJ; Oghabian MA
    Contrast Media Mol Imaging; 2015; 10(3):225-36. PubMed ID: 25327822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.